Tonix Pharmaceuticals Holding Corp.

07/21/2026 | Press release | Distributed by Public on 07/21/2026 14:06

Management Change/Compensation (Form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On July 20, 2026, Dr. Gregory M. Sullivan informed Tonix Pharmaceuticals Holding Corp. (the "Company") that he will retire from his role as Chief Medical Officer of the Company, effective August 20, 2026.

Tonix Pharmaceuticals Holding Corp. published this content on July 21, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on July 21, 2026 at 20:10 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]